Home » Wound Care Biologics Market

Global Wound Care Biologics Market By Product (Biological Skin Substitutes, Human Donor Tissue-derived Products, Acellular Animal-derived Products, Biosynthetic Products and Topical Agents) By Wound Type (Ulcers, Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers, Other Ulcers, Surgical & Traumatic Wounds and Burns) By End Users (Hospitals, Ambulatory Surgery Centers, Burn Care Centers & Wound Clinics)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Price: $4999

Published: | Report ID: 16761 | Report Format : PDF

Key Highlights of the report

How are the major segments performing in the Wound Care Biologics market?

  • The wound biologics care market’s biological skin replacements category had the biggest market share in 2022 and is projected to grow at the quickest rate during the forecast period.
  • In 2022, the hospital sector held the largest proportion. One of the main drivers for the segment is the rising need for treating acute and chronic wounds.

What is the Market Size of Wound Care Biologics regarding value?

The global wound care biologics market is anticipated to grow at a substantial CAGR of 5.2% in the upcoming years. The global wound care biologics industry was estimated to be worth USD 1749.5 million in 2022 and was expected to be worth USD 2494.7 million by 2028.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Which region dominated the wound care biologics market?

During the anticipated years, North America is anticipated to control the wound care biologics market. This is primarily related to the region’s increased burn injury cases and diabetes population growth. Furthermore, one of the major factors anticipated to support the expansion of the advanced wound care management market in the upcoming years is the rising incidence of several lifestyle conditions that result in chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers.

How is US Market Performing in the wound care biologics market?

More than 29 million Americans have diabetes, and every year, about 2 million of them will develop a diabetic foot ulcer or another non-healing sore, according to Mission Regional Medical Center in May 2021. Moreover, 37.3 million Americans, or 1 in 10, have diabetes, according to the Centers for Disease Control and Prevention Updates from January 2022. Ninety-six million adult Americans, or more than one in three, have prediabetes. As a result, it is predicted that throughout the projection period, demand for wound care biologics will increase, and the market will expand more quickly due to the rising incidence of diabetes, which is a significant risk factor for the formation of foot ulcers.

How is the economy impacting global wound care biologics growth?

Growing inflation rates have significantly influenced the purchasing power of consumers in several countries. Because people prioritize their needs during a recession, their purchase decisions may be impacted. Market liquidity may also decrease. The Russia-Ukraine War severely harmed countries that imported commodities from Russia and Ukraine. The Covid-19 pandemic may also drive doctors to forego needless medicines to treat individuals with Covid-19 infections properly. Consequently, each of these factors has the potential to limit market expansion.

REPORT ATTRIBUTE DETAILS
Wound Care Biologics Market by Volume Yes
Wound Care Biologics Market by Value Yes
Wound Care Biologics Market, Tornado Analysis Yes
Wound Care Biologics Market, STAR Analysis Yes
Wound Care Biologics Market, SRC Analysis Yes
Wound Care Biologics Market, Import-Export Data Yes (On Demand)
Wound Care Biologics Market Pricing Analysis Yes (On Demand)
Wound Care Biologics Market Segment Analysis By Product (Biological Skin Substitutes, Human Donor Tissue-derived Products, Acellular Animal-derived Products, Biosynthetic Products and Topical Agents)

By Wound Type (Ulcers, Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers, Other Ulcers, Surgical & Traumatic Wounds and Burns)

By End Users (Hospitals, Ambulatory Surgery Centers, Burn Care Centers & Wound Clinics)

Wound Care Biologics Market, Regional Analysis North America (US and Canada)

Europe (Germany, UK, France, Italy, Spain, and the Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, South East Asia, and Rest of Asia Pacific)

Latin America (Brazil, Mexico, and Rest of Latin America)

Middle East and Africa (GCC Countries, South Africa, and Rest of Middle East and Africa)

Wound Care Biologics Market Key Companies Smith & Nephew, Molnlycke health care, Integra Lifesciences Corporation, Wright Medical, MiMedx Group, Kerecis, Amnio Technology, and Anika Therapeutics
Wound Care Biologics Market Competitive Landscape Market Share Analysis

Competitive Benchmarking

Key Players Market Positioning

Geographical Presence Analysis

Major Strategies Adopted

What is the competitive environment of the wound care biologics market?

Most companies are using new technologies and strategies to expand their market shares. Players in the wound care biologics market heavily commit to extensive R&D projects to introduce novel products and offer trustworthy services. Expansion of the product portfolio, mergers, and acquisitions are common significant strategies key players use. For instance, a tri-layer skin graft called Artacent AC was introduced by the biologics business Tides Medical in July 2022. It is intended to be used to treat complex or challenging-to-treat wounds. The department of defense awarded MIMEDX USD 4.6 million in May 2022 to investigate PURION-processed Dehydrated Human Amnion Chorion Membrane (DHACM) to advance the treatment of burns and wounds sustained during warfare.

Executive Summary

What are the key trends in the Wound Care Biologics market?

  • For treating chronic wounds, such as diabetic foot ulcers and venous leg ulcers, as well as burn injuries, injuries sustained in auto accidents, and other ailments, biological skin substitutes are highly suggested.
  • The prevalence of diabetic foot ulcers will inevitably increase as more people are diagnosed each year. Therefore, the need for wound care biologics is anticipated to rise over the forecast period, supporting market expansion.

What is the market scenario of the Wound Care Biologics Market?

Wound care biologics are medications taken from or partially manufactured from natural sources and used to treat and manage infections. Inflammation, the buildup of fibrous tissue, the deposit of collagen, the development of epithelial cell layers, and other disruptions all play a part in the complicated wound healing process. Biologically active substances can be used in biological wound healing treatments to reactivate the body’s repair system. For instance, active biomolecules produced from plants with antibacterial, anti-inflammatory, or antioxidant activities have been effective in speeding up the healing of wounds. Skin substitutes, bio-membranes, scaffolds, hydro conductive dressings, and biologics are a few examples of recent technological developments in wound healing.

Wound Care Biologics Market

Which are the key investments by the wound care biologics market players?

Key players are implementing various methods, including product launches, alliances, and mergers and acquisitions, to strengthen their position in the business. For instance, to hasten the development of its advanced wound management product portfolio, Smith & Nephew PLC purchased Osiris Therapeutics, Inc. in April 2019. It was believed that the campaign would increase their clientele. Additionally, Amnio Technology, a producer of amniotic tissue allografts, added two new items to its PalinGen membrane product line in February 2022.

Some major wound care biologics market players are Smith & Nephew, Molnlycke health care, Integra Lifesciences Corporation, Wright Medical, MiMedx Group, Kerecis, Amnio Technology, and Anika Therapeutics.

What are the Major Driving Factors for the Wound Care Biologics Market?

The increase in wound care treatment and management programs is one of the key factors propelling the growth of the wound care biologics market. The rise in chronic wounds, particularly foot ulcers, among the diabetic population and the rise in diabetes occurrences caused by obesity, poor food, and physical inactivity are driving market expansion. The tremendous burden of diseases, the focus on creating better treatment choices, and the application of technology to combat inflammation, tissue accumulation, collagen deposition, and the production of epithelial cell layers all impact the market. The federal government’s increased investment in encouraging these solutions further impacts the market. Additionally, the market for wound care biologics is positively impacted by the rise in healthcare spending, improvements in healthcare infrastructure, and rising demand for extended care delivery.

What are the Major Risks for the Wound Care Biologics Market?

The high cost of wound care biologics and wound treatment is anticipated to restrain market expansion. The potential of skin substitute failure is anticipated to present a challenge to the wound care biologics industry throughout the forecast period.

Which is the key product in the wound care biologics market?

The wound biologics care market’s biological skin replacements category had the greatest market share in 2022 and is predicted to increase at the quickest rate during the forecast period. Biological skin substitutes are a diverse range of materials used to cover and close wounds. Patients with severe burns typically employ biological skin replacements. The biological skin substitutes also enable the development of a more natural new dermis, ensuring quick wound healing. The categories of allograft, xenograft, and biosynthetic goods are further divided under the biological skin substitutes section. Increased chronic illnesses and burn injuries are expected to be the main drivers of category expansion. For instance, according to the American Burn Association, in 2017, there were reported to be 486,000 burn injuries between 2011 and 2015. Additionally, according to the American Burn Association in 2017, burn injuries were one of the main causes of unintentional death and injury in the United States.

How is the wound care biologics market performing in regions?

In 2022, the market was dominated by North America. The market in North America is predicted to be driven by an increase in traffic accidents, a rise in the frequency of chronic diseases, and numerous major competitors in the area. Throughout the projected period, this market is also anticipated to be driven by improvements in healthcare infrastructure and the availability of trained experts.

Over the forecast period, Asia Pacific is anticipated to experience the quickest growth. It is projected that the presence of growing nations like China, India, and Japan will accelerate market expansion in the Asia Pacific area. Additionally, throughout the projection period, the prevalence of chronic diseases, particularly diabetes, is predicted to increase.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

What are the major players planning for the future of the wound care biologics market?

Market players constantly launch new items and employ various growth strategies in their niche markets, likely to encourage market growth. For example, To offer an exclusive version of WoundGenex’s Premier Graft Program for its clients across the nation in March 2022, WoundGenex joined forces with MiMedx Group, Inc., a pioneering placental biologics firm. This cooperation will give doctors easy access to market-leading allograft products.

Segmentation of Global Wound Care Biologics Market-

Global Wound Care Biologics Market – By Product

  • Biological Skin Substitutes
  • Human Donor Tissue-derived Product
  • Acellular Animal-derived Product
  • Biosynthetic Products
  • Topical Agents

Global Wound Care Biologics Market – By Wound Type

  • Ulcers
  • Diabetic Foot Ulcers
  • Venous Ulcers
  • Pressure Ulcers
  • Other Ulcers
  • Surgical & Traumatic Wounds
  • Burns

Global Wound Care Biologics Market – By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Burn Care Centers & Wound Clinics

Global Wound Care Biologics Market – By Region

  • North America
    • U.S
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Wound Care Biologics Market
2.2. Global Wound Care Biologics Market, By Product
2.3. Global Wound Care Biologics Market, By Wound Type
2.4. Global Wound Care Biologics Market, By End User
2.5. Global Wound Care Biologics Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Wound Care Biologics Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Product
3.5.2. Wound Type
3.5.3. End User
3.5.4. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Wound Type Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. COVID 19 Impact Analysis
6.1. Global Wound Care Biologics Market Pre Vs Post COVID 19, 2021 – 2030
6.2. Impact on Import & Export
6.3. Impact on Demand & Supply

7. Global Wound Care Biologics Market
7.1. Global Wound Care Biologics Market, by Product, 2017-2030(US$ Bn)
7.1.1. Overview
7.1.2. Global Wound Care Biologics Market, By Product, 2022 vs 2030 (in%)
7.1.3. Global Wound Care Biologics Market, By Biological Skin Substitutes, 2017-2030 (US$ Bn)
7.1.4. Global Wound Care Biologics Market, By Human Donor Tissue-derived Product, 2017-2030 (US$ Bn)
7.1.5. Global Wound Care Biologics Market, By Acellular Animal-derived Product, 2017-2030 (US$ Bn)
7.1.6. Global Wound Care Biologics Market, By Biosynthetic Products, 2017-2030 (US$ Bn)
7.1.7. Global Wound Care Biologics Market, By Topical Agents, 2017-2030 (US$ Bn)
7.2. Global Wound Care Biologics Market, by Wound Type, 2017-2030(US$ Bn)
7.2.1. Overview
7.2.2. Global Wound Care Biologics Market, By Wound Type, 2022 vs 2030 (in%)
7.2.3. Global Wound Care Biologics Market, By Ulcers, 2017-2030 (US$ Bn)
7.2.4. Global Wound Care Biologics Market, By Diabetic Foot Ulcers, 2017-2030 (US$ Bn)
7.2.5. Global Wound Care Biologics Market, By Venous Ulcers, 2017-2030 (US$ Bn)
7.2.6. Global Wound Care Biologics Market, By Pressure Ulcers, 2017-2030 (US$ Bn)
7.2.7. Global Wound Care Biologics Market, By Other Ulcers, 2017-2030 (US$ Bn)
7.2.8. Global Wound Care Biologics Market, By Surgical & Traumatic Wounds, 2017-2030 (US$ Bn)
7.2.9. Global Wound Care Biologics Market, By Burns, 2017-2030 (US$ Bn)
7.3. Global Wound Care Biologics Market, by End User, 2017-2030(US$ Bn)
7.3.1. Overview
7.3.2. Global Wound Care Biologics Market, By End User, 2022 vs 2030 (in%)
7.3.3. Global Wound Care Biologics Market, By Hospitals, 2017-2030 (US$ Bn)
7.3.4. Global Wound Care Biologics Market, By Ambulatory Surgery Centers, 2017-2030 (US$ Bn)
7.3.5. Global Wound Care Biologics Market, By Burn Care Centers & Wound Clinics, 2017-2030 (US$ Bn)

8. North America Wound Care Biologics Market Analysis
8.1. North America Wound Care Biologics Market, by Product, 2017-2030(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Wound Care Biologics Market, by Wound Type, 2017-2030(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Wound Care Biologics Market, by End User, 2017-2030(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Wound Care Biologics Market, by Country, 2017-2030 (US$ Bn)
8.4.1. U.S.
8.4.1.1. U.S. Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
8.4.1.2. U.S. Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
8.4.1.3. U.S. Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
8.4.1.4. U.S. Wound Care Biologics, By End User, 2017-2030 (US$ Bn)
8.4.2. Canada
8.4.2.1. Canada Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
8.4.2.2. Canada Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
8.4.2.3. Canada Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
8.4.2.4. Canada Wound Care Biologics, By End User, 2017-2030 (US$ Bn)

9. Europe Wound Care Biologics Market Analysis
9.1. Europe Wound Care Biologics Market, by Product, 2017-2030(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Wound Care Biologics Market, by Wound Type, 2017-2030(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Wound Care Biologics Market, by End User, 2017-2030(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Wound Care Biologics Market, by Country, 2017-2030 (US$ Bn)
9.4.1. Germany
9.4.1.1. Germany Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.1.2. Germany Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
9.4.1.3. Germany Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
9.4.1.4. Germany Wound Care Biologics, By End User, 2017-2030 (US$ Bn)
9.4.2. France
9.4.2.1. France Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.2.2. France Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
9.4.2.3. France Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
9.4.2.4. France Wound Care Biologics, By End User, 2017-2030 (US$ Bn)
9.4.3. UK
9.4.3.1. UK Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.3.2. UK Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
9.4.3.3. UK Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
9.4.3.4. UK Wound Care Biologics, By End User, 2017-2030 (US$ Bn)
9.4.4. Italy
9.4.4.1. Italy Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.4.2. Italy Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
9.4.4.3. Italy Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
9.4.4.4. Italy Wound Care Biologics, By End User, 2017-2030 (US$ Bn)
9.4.5. Spain
9.4.5.1. Spain Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.5.2. Spain Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
9.4.5.3. Spain Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
9.4.5.4. Spain Wound Care Biologics, By End User, 2017-2030 (US$ Bn)
9.4.6. Rest of Europe
9.4.6.1. Rest of Europe Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.6.2. Rest of Europe Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
9.4.6.3. Rest of Europe Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
9.4.6.4. Rest of Europe Wound Care Biologics, By End User, 2017-2030 (US$ Bn)

10. Asia Pacific Wound Care Biologics Market Analysis
10.1. Asia Pacific Wound Care Biologics Market, by Product, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Wound Care Biologics Market, by Wound Type, 2017-2030(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Wound Care Biologics Market, by End User, 2017-2030(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Wound Care Biologics Market, by Country, 2017-2030 (US$ Bn)
10.4.1. China
10.4.1.1. China Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.1.2. China Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
10.4.1.3. China Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
10.4.1.4. China Wound Care Biologics, By End User, 2017-2030 (US$ Bn)
10.4.2. Japan
10.4.2.1. Japan Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.2.2. Japan Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
10.4.2.3. Japan Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
10.4.2.4. Japan Wound Care Biologics, By End User, 2017-2030 (US$ Bn)
10.4.3. India
10.4.3.1. India Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.3.2. India Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
10.4.3.3. India Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
10.4.3.4. India Wound Care Biologics, By End User, 2017-2030 (US$ Bn)
10.4.4. South Korea
10.4.4.1. South Korea Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.4.2. South Korea Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
10.4.4.3. South Korea Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
10.4.4.4. South Korea Wound Care Biologics, By End User, 2017-2030 (US$ Bn)
10.4.5. South-East Asia
10.4.5.1. South-East Asia Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.5.2. South-East Asia Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
10.4.5.3. South-East Asia Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
10.4.5.4. South-East Asia Wound Care Biologics, By End User, 2017-2030 (US$ Bn)
10.4.6. Rest of Asia Pacific
10.4.6.1. Rest of Asia Pacific Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.6.2. Rest of Asia Pacific Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
10.4.6.3. Rest of Asia Pacific Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
10.4.6.4. Rest of Asia Pacific Wound Care Biologics, By End User, 2017-2030 (US$ Bn)

11. Latin America Wound Care Biologics Market Analysis
11.1. Latin America Wound Care Biologics Market, by Product, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Wound Care Biologics Market, by Wound Type, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Wound Care Biologics Market, by End User, 2017-2030(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Wound Care Biologics Market, by Country, 2017-2030 (US$ Bn)
11.4.1. Brazil
11.4.1.1. Brazil Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.1.2. Brazil Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
11.4.1.3. Brazil Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
11.4.1.4. Brazil Wound Care Biologics, By End User, 2017-2030 (US$ Bn)
11.4.2. Mexico
11.4.2.1. Mexico Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.2.2. Mexico Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
11.4.2.3. Mexico Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
11.4.2.4. Mexico Wound Care Biologics, By End User, 2017-2030 (US$ Bn)
11.4.3. Rest of Latin America
11.4.3.1. Rest of Latin America Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.3.2. Rest of Latin America Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
11.4.3.3. Rest of Latin America Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
11.4.3.4. Rest of Latin America Wound Care Biologics, By End User, 2017-2030 (US$ Bn)

12. Middle East and Africa Wound Care Biologics Market Analysis
12.1. Middle East and Africa Wound Care Biologics Market, by Product, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Wound Care Biologics Market, by Wound Type, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Wound Care Biologics Market, by End User, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Wound Care Biologics Market, by Country, 2017-2030 (US$ Bn)
12.4.1. GCC Countries
12.4.1.1. GCC Countries il Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.1.2. GCC Countries Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
12.4.1.3. GCC Countries Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
12.4.1.4. GCC Countries Wound Care Biologics, By End User, 2017-2030 (US$ Bn)
12.4.2. South Africa
12.4.2.1. South Africa Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.2.2. South Africa Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
12.4.2.3. South Africa Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
12.4.2.4. South Africa Wound Care Biologics, By End User, 2017-2030 (US$ Bn)
12.4.3. Rest of Middle East and Africa
12.4.3.1. Rest of Middle East and Africa Wound Care Biologics Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.3.2. Rest of Middle East and Africa Wound Care Biologics, By Product, 2017-2030 (US$ Bn)
12.4.3.3. Rest of Middle East and Africa Wound Care Biologics, By Wound Type, 2017-2030 (US$ Bn)
12.4.3.4. Rest of Middle East and Africa Wound Care Biologics, By End User, 2017-2030 (US$ Bn)

13. Company Profiles
13.1. Smith & Nephew
13.1.1. Company Overview
13.1.2. Products/Acellular Animal-derived Product Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2022)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Molnlycke health care
13.3. Integra Lifesciences Corporation
13.4. Wright Medical
13.5. MiMedx Group
13.6. Kerecis
13.7. Amnio Technology
13.8. Anika Therapeutics
13.9. Others

List of Figures
FIG. 1 Global Wound Care Biologics Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Wound Care Biologics Market Segmentation
FIG. 4 Global Wound Care Biologics Market, by Product, 2022 (US$ Bn)
FIG. 5 Global Wound Care Biologics Market, by Wound Type, 2022 (US$ Bn)
FIG. 6 Global Wound Care Biologics Market, by End User, 2022 (US$ Bn)
FIG. 7 Global Wound Care Biologics Market, by Geography, 2022 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Product, 2022
FIG. 9 Attractive Investment Proposition, by Wound Type, 2022
FIG. 10 Attractive Investment Proposition, by End User, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key Wound Care Biologics Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key Wound Care Biologics Market Manufacturers, 2022
FIG. 14 Global Wound Care Biologics Market Value Contribution, By Product, 2022 & 2030 (Value %)
FIG. 15 Global Wound Care Biologics Market, by Biological Skin Substitutes, Value, 2017-2030 (US$ Bn)
FIG. 16 Global Wound Care Biologics Market, by Human Donor Tissue-derived Product, Value, 2017-2030 (US$ Bn)
FIG. 17 Global Wound Care Biologics Market, by Acellular Animal-derived Product, Value, 2017-2030 (US$ Bn)
FIG. 18 Global Wound Care Biologics Market, by Biosynthetic Products, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Wound Care Biologics Market, by Topical Agents, Value, 2017-2030 (US$ Bn)
FIG. 20 Global Wound Care Biologics Market Value Contribution, By Wound Type, 2022 & 2030 (Value %)
FIG. 21 Global Wound Care Biologics Market, by Ulcers, Value, 2017-2030 (US$ Bn)
FIG. 22 Global Wound Care Biologics Market, by Diabetic Foot Ulcers, Value, 2017-2030 (US$ Bn)
FIG. 23 Global Wound Care Biologics Market, by Pressure Ulcers, Value, 2017-2030 (US$ Bn)
FIG. 24 Global Wound Care Biologics Market, by Venous Ulcers, Value, 2017-2030 (US$ Bn)
FIG. 25 Global Wound Care Biologics Market, by Other Ulcers, Value, 2017-2030 (US$ Bn)
FIG. 26 Global Wound Care Biologics Market, by Surgical & Traumatic Wounds, Value, 2017-2030 (US$ Bn)
FIG. 27 Global Wound Care Biologics Market, by Burns, Value, 2017-2030 (US$ Bn)
FIG. 28 Global Wound Care Biologics Market Value Contribution, By End User, 2022 & 2030 (Value %)
FIG. 29 Global Wound Care Biologics Market, by Hospitals, Value, 2017-2030 (US$ Bn)
FIG. 30 Global Wound Care Biologics Market, by Ambulatory Surgery Centers, Value, 2017-2030 (US$ Bn)
FIG. 31 Global Wound Care Biologics Market, by Burn Care Centers & Wound Clinics, Value, 2017-2030 (US$ Bn)
FIG. 32 U.S. Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 33 Canada Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 34 Germany Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 35 France Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 36 U.K. Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 37 Italy Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 38 Spain Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 39 Rest of Europe Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 40 China Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 41 Japan Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 42 India Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 43 South Korea Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 44 Southeast Asia Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 45 Rest of Asia Pacific Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 46 Latin America Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 47 Brazil Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 48 Mexico Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 49 Rest of Latin America Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 50 Middle East & Africa Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 51 GCC Countries Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 52 South Africa Wound Care Biologics Market, 2017-2030 (US$ Bn)
FIG. 53 Rest of Middle East and Africa Wound Care Biologics Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Wound Care Biologics Market
TABLE 2 Global Wound Care Biologics Market, by Competitive Benchmarking, 2022
TABLE 3 Global Wound Care Biologics Market, by Geographical Presence Analysis, 2022
TABLE 4 Global Wound Care Biologics Market, by Key Strategies Analysis, 2022
TABLE 5 Global Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 6 Global Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 7 Global Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 8 Global Wound Care Biologics Market, by Geography, 2017-2030 (US$ Bn)
TABLE 9 North America Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 10 North America Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 11 North America Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 12 North America Wound Care Biologics Market, by Country, 2017-2030 (US$ Bn)
TABLE 13 US Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 14 US Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 15 US Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 16 Canada Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 17 Canada Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 18 Canada Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 19 Europe Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 20 Europe Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 21 Europe Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 22 Europe Wound Care Biologics Market, by Country, 2017-2030 (US$ Bn)
TABLE 23 Germany Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 24 Germany Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 25 Germany Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 26 France Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 27 France Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 28 France Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 29 UK Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 30 UK Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 31 UK Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 32 Italy Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 33 Italy Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 34 Italy Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 35 Spain Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 36 Spain Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 37 Spain Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 38 Rest of Europe Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 39 Rest of Europe Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 40 Rest of Europe Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 41 Asia Pacific Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 42 Asia Pacific Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 43 Asia Pacific Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 44 Asia Pacific Wound Care Biologics Market, by Country, 2017-2030 (US$ Bn)
TABLE 45 China Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 46 China Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 47 China Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 48 Japan Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 49 Japan Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 50 Japan Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 51 India Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 52 India Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 53 India Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 54 South Korea Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 55 South Korea Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 56 South Korea Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 57 South East Asia Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 58 South East Asia Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 59 South East Asia Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 60 Rest of Asia Pacific Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 61 Rest of Asia Pacific Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 62 Rest of Asia Pacific Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 63 Latin America Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 64 Latin America Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 65 Latin America Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 66 Latin America Wound Care Biologics Market, by Country, 2017-2030 (US$ Bn)
TABLE 67 Brazil Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 68 Brazil Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 69 Brazil Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 70 Mexico Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 71 Mexico Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 72 Mexico Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 73 Rest of Latin America Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 74 Rest of Latin America Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 75 Rest of Latin America Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 76 Middle East and Africa Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 77 Middle East and Africa Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 78 Middle East and Africa Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 79 Middle East and Africa Wound Care Biologics Market, by Country, 2017-2030 (US$ Bn)
TABLE 80 GCC Countries Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 81 GCC Countries Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 82 GCC Countries Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 83 South Africa Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 84 South Africa Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 85 South Africa Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)
TABLE 86 Rest of Middle East and Africa Wound Care Biologics Market, by Product, 2017-2030 (US$ Bn)
TABLE 87 Rest of Middle East and Africa Wound Care Biologics Market, by Wound Type, 2017-2030 (US$ Bn)
TABLE 88 Rest of Middle East and Africa Wound Care Biologics Market, by End User, 2017-2030 (US$ Bn)

Frequently Asked Questions:

How does COVID-19 Impact the global wound care biologics market?

COVID-19 has had a substantial impact on the market due to the outbreak of the COVID-19 pandemic, which directly suspended unnecessary medical procedures.

Which is the leading region of the market for wound care biologics?

North America accounted for the most heightened share market.

What are the key drivers for wound care biologics market growth?

Increasing cases of diabetes and a rise in incidences of chronic wounds drive the wound care biologics market.

Which is the major product segment in the wound care biologics market?

The biological skin substitutes segment had a major share in the global market in 2022.

Which is the major segment in the wound care biologics market by the end user?

The hospital’s segment had a major share in the global market.

Qatar Dental Care Market

Published:
Report ID: 30608

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market

Published:
Report ID: 33712

Tracheitis Treatment Market

Published:
Report ID: 33694

Neuralgia Treatment Market

Published:
Report ID: 33681

Clostridioides Difficile (C. diff) Treatment Market

Published:
Report ID: 33667

Hepatic Encephalopathy Market

Published:
Report ID: 33664

Sphingosine-1-Receptor Modulators Drugs Market

Published:
Report ID: 33649

Guidewires Market

Published:
Report ID: 6790

3D Printing for Personalized Healthcare Market

Published:
Report ID: 33603

Neuromyelitis Optica Therapy Market

Published:
Report ID: 33583

In Vitro Diagnostic (IVD) Kit Market

Published:
Report ID: 33580

North America Medical Headgears Market

Published:
Report ID: 33554

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN